Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application into routine care remains limited. Opportunely, several implementation studies and programs have been initiated over recent years. This article presents an overview of these studies and identifies current re...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical pharmacology and therapeutics 2017-03, Vol.101 (3), p.341-358
Main Authors:	van der Wouden, CH, Cambon‐Thomsen, A, Cecchin, E, Cheung, KC, Dávila‐Fajardo, CL, Deneer, VH, Dolžan, V, Ingelman‐Sundberg, M, Jönsson, S, Karlsson, MO, Kriek, M, Mitropoulou, C, Patrinos, GP, Pirmohamed, M, Samwald, M, Schaeffeler, E, Schwab, M, Steinberger, D, Stingl, J, Sunder‐Plassmann, G, Toffoli, G, Turner, RM, van Rhenen, MH, Swen, JJ, Guchelaar, H‐J
Format:	Article
Language:	English
Subjects:	Biomarkers Cost-Benefit Analysis Electronic Health Records - organization & administration Europe Genotype Humans Pharmacogenomic Testing - economics Pharmacogenomic Testing - methods Pharmacogenomic Testing - statistics & numerical data Pharmacogenomic Testing - trends Practice Guidelines as Topic Precision Medicine - methods Prospective Studies Research Design Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!